Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Bruker Posts 11% Organic Growth In Q4 Sales, Issues FY22 Outlook

Bruker Corp's (NASDAQ:BRKRQ4 revenues were $683.5 million, up 8.9% Y/Y (11.4% organically) and beating the Wall Street estimate of $663.88 million.

  • The Company saw a 0.3% positive effect on revenues from acquisitions, while foreign currency translation had a negative effect of 2.8%.
  • Adjusted EPS increased from $0.58 to $0.59, surpassing the consensus of $0.58.
  • Q4 FY21 Bruker Scientific Instruments revenues of $629.2 million increased 9.5% Y/Y (11.8% organic).
  • Bruker Energy & Supercon Technologies revenues increased 5.7% Y/Y to $57.8 million (6.8% organic).
  • The gross margin remained almost stagnant at 51% on an adjusted basis. The operating margin declined from 22.5% to 21%.
  • Guidance: For FY 2022, Bruker expects approximately 5% to 7% Y/Y revenue growth, including organic revenue growth of roughly 6% - 8%, M&A contribution of approximately 1%, and foreign currency translation headwind of around -2%.
  • In FY 2022, Bruker expects an adjusted operating margin expansion of 30 bps to 60 bps year-over-year, from 19.4% in FY 2021. 
  • Bruker expects FY 2022 non-GAAP EPS of $2.29 to $2.33, compared to the consensus of $2.29.
  • Price Action: BRKR shares traded 5.05% lower at $67.90 on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.